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Linkage disequilibrium mapping of chromosome Xp11 for a schizophrenia susceptibility locus SIR - There have been at least three linkage studies showing that a gene responsible for schizophrenia may reside within Xp11 although Okoro et al failed to replicate this finding. [1] [2] [3] [4] In family-based association studies, we found that the loci for monoamine oxidase (MAO) type B and for synaptophysin (SYP) were associated with schizophrenia in male individuals. 5, 6 To further validate these preliminary findings and then to narrow their location to a minimal region, it was thought important to conduct linkage disequilibrium (LD) mapping with a high density of DNA markers along Xp11 where both MAOB and SYP genes are located. In the present study, 19 polymorphic microsatellites were used as genetic markers for LD mapping of Xp11. Their sequence data were retrieved from a database through a website of the National Center for Biotechnology Information (NCBI), Bethesda, USA (http://www.ncbi. nlm.nih.gov/Entrez). Their genetic order was as follows: Xpter -DXS8012 -DXS993 -WI-7054 -AFMa212ZG1 -DXS6745 -DXS8085 -DXS1201 -DXS1207 -DXS8035 -DXS8080 -DXS8054 -DXS8026 -DXS1003 -DXS1208 -DXS1039 -DXS8023 -DXS1190 -DXS8024 -DXS988 -Xcen. The interval between two DNA markers was on average about one centimorgan (cM). To enhance the resolution of PCR fragments by gel electrophoresis, the primers, specific for each marker locus, were designed based on the known sequence data retrieved from the GenBank databases so that the predicted length of PCR products was in the range of 90-120 bp.
Eighty-two male individuals affected with schizophrenia came voluntarily with their biological mothers to the Schizophrenia Association of Great Britain from all parts of the United Kingdom. They were all Caucasian. These patients were diagnosed as having schizophrenia by the psychiatrists who initially treated them. All the subjects gave informed consent for taking blood samples for genetic studies. Genomic DNA used for PCR amplification was extracted from whole blood samples using the Micromix 200 kit (Talent, Italy). The PCR amplification of a target sequence was performed in a 25-l reaction volume containing 10 mM Tri-HCl (pH 8. The PCR products were electrophoresed in 12% polyacrylamide gels (Bio-Rad) followed by ethidium bromide staining. Individual alleles or genotypes were identified based on fragment length of the PCR products. The transmission/disequilibrium test (TDT) and the likelihood-based LD analysis were applied to process the genotyping data. 7, 8 In such a family-based study, the allele transmitted from mothers to affected offspring was used as a 'case' and the non-transmitted as a 'control'. The results demonstrated that markers DXS8026 and DXS1208 were possibly associated with schizophrenia. The and P values are listed in Table 1 . The likelihood-based LD analysis did not show allelic association of the other 17 markers with schizophrenia. The NCBI website search (http://www.ncbi. nlm.nih.gov/) showed that the DXS1208 locus was 35 kb away from the SYP gene and that the MAOB gene was within the region bordered by DXS993 and DXS1201.
The present study further confirms our previous findings that the SYP gene is likely to be associated with schizophrenia although a false positive result cannot be ruled out because of the low significance value for marker DXS1208 ( Table 1) . A difficult problem in the genetic analysis of a complex trait is to know whether a result is statistically significant. It is very likely that the type I error probability (the false positive rate) will inflate with the number of loci being tested if the P = 0.05 level is used for multi-marker analyses. To solve this problem, it has been proposed that the P = 0.05 level, which is usually required for testing a single locus, should be divided by the number of loci tested with a multi-marker analysis. 9 However, re-setting a significance level may lose the power of test. It would be helpful to replicate a positive finding by analysing nearby markers. The false positive rate will be largely reduced if nearby markers also show allelic association with a disease. Moreover, the extent of LD should also be taken into account in evaluating a positive result. The genetic distance between spaced markers on a high density linkage map of the human genome is about 1 cM on average (corresponding to a physical distance of 1 Mb). This resolution may be too low for LD mapping of a disease-related gene. Recently, a simulation study has indicated that a useful level of LD is unlikely to extend beyond an average distance of roughly 3 kb in the general human population, and no LD is observed at 0.03 cM (about 30 kb) or greater. 10 Accordingly, the physical distance between a candidate gene studied and a genetic marker should be checked before any conclusion is drawn. The average genetic distance between markers used in the present study is 1 cM and two positive marker loci, DXS1208 and DXS8026, have been found. However, the NCBI website search demonstrates that the physical distance is obtained only between DXS1208 and the SYP gene but not between DXS8026 and a nearby gene, as the data of genomic DNA sequence containing or overlapping with the DXS8026 locus are not available in the public domain at the moment.
There are two types of MAO, types A and B, in humans. These two MAO genes are localized within a region of 240 kb and are arranged in a tail-to-tail configuration, with the 3Ј-coding sequences separated by about 50 kb. 11 Intron 2 of both genes contains a microsatellite marker. 12 In a previous study, we genotyped these two markers and found that the MAOB locus rather than the MAOA locus was associated with schizophrenia. 5 Data of the genomic DNA sequence adjacent to the 5Ј-end of the MAOB gene are not yet accessible in the public domain so that it may be too early to draw a conclusion of whether or not the MAOB gene is really associated with schizophrenia.
Since there is an equal incidence of schizophrenia in both sexes, loci on autosomal chromosomes may make a genetic contribution to schizophrenia. However, gender differences in clinical presentation are thought to be an important characteristic of schizophrenia. Men have an earlier age of onset, a poorer premorbid history, more negative symptoms, differential neurocognitive functioning, a poorer course, a poorer response to neuroleptic drugs, a lower family morbidity risk, and differential structural and functional brain abnormalities as compared with schizophrenic women. Possibly genes on the X chromosome may be responsible for the gender differences in schizophrenia.
